Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion support in acquired coagulation disorders.

L L Phillips

    Clinics in Haematology
    |February 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Correct transfusion support for acquired coagulation defects requires both laboratory and clinical evidence of bleeding. Fresh frozen plasma is ideal before surgery, while platelet transfusions should be timed after certain procedures.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Vision of State Medical Service.

    The Hospital·2018
    Same author

    In defense of their families: working-class women, alcohol, and politics in revolutionary Russia.

    Journal of women's history·2011
    Same author

    The effect of heparin on endotoxin shock in the rat.

    The American journal of pathology·2009
    Same author

    Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury.

    Journal of neuroscience research·2006
    Same author

    Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis.

    Experimental neurology·2005
    Same author

    Interactive pathology following traumatic brain injury modifies hippocampal plasticity.

    Restorative neurology and neuroscience·2002
    Same journal

    Myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.

    Clinics in haematology·1986
    Same journal

    Myelodysplastic syndromes: natural history and features of prognostic importance.

    Clinics in haematology·1986
    Same journal

    Pathogenesis and clinical variations in the myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    The treatment of myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    Secondary myelodysplastic syndromes and leukaemias.

    Clinics in haematology·1986
    See all related articles

    Area of Science:

    • Hematology
    • Transfusion Medicine
    • Surgical Hemostasis

    Background:

    • Acquired coagulation defects necessitate careful transfusion management.
    • Improper use of blood products can lead to adverse outcomes.

    Purpose of the Study:

    • To outline appropriate transfusion strategies for acquired coagulation defects.
    • To emphasize the importance of integrating laboratory and clinical findings.

    Main Methods:

    • Review of transfusion guidelines for coagulation disorders.
    • Analysis of timing for plasma and platelet product administration.

    Main Results:

    • Transfusion is indicated for laboratory-confirmed defects with active bleeding.
    • Fresh frozen plasma is recommended pre-operatively due to short half-life factors.

    Related Experiment Videos

  • Platelet transfusions are best administered after completion of procedures with platelet-consuming characteristics.

    • Conclusions:

    • Optimal transfusion support hinges on judicious use of blood products.
    • Clinical bleeding assessment is paramount alongside laboratory data for treatment decisions.
    • Strategic timing of transfusions, particularly for plasma and platelets, optimizes therapeutic efficacy.